EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Klotho Deficiency Impairs Distal Potassium Homeostasis Through mTORC1 ‐Dependent Suppression of ROMK

Wakako Kawarazaki iD, Nobuhiro Ayuzawa, Mitsuhiro Nishimoto iD, Daigoro Hirohama iD, Kohei Ueda iD, Takeshi Marumo iD, Toshiro Fujita iD

Acta Physiologica · 2026

DOI: 10.1111/apha.70325 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Physiologica, 2026. Verfasst von Wakako Kawarazaki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Basic Medical Research, International University of Health and Welfare (IUHW), Narita, Chiba, Japan. Hauptthemen laut MEDLINE: Mechanistic Target of Rapamycin Complex 1, Potassium, Homeostasis, Potassium Channels, Inwardly Rectifying. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, SENSHIN Medical Research Foundation, Takeda Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Hyperkalemia is prevalent in the elderly, and underlying molecular mechanisms remain incompletely understood. We hypothesized that Klotho deficiency, a feature of aging, impairs renal potassium homeostasis and contributes to hyperkalemia.

Methods

Klotho heterozygous knockout (KLhet) mice, characterized by reduced Klotho levels, were used to investigate determinants of potassium handling, including renal outer medullary potassium channel (ROMK)1, the epithelial sodium channel (ENaC), which provides the driving force for ROMK‐mediated potassium secretion, and plasma aldosterone concentration (PAC).

Results

KLhet mice developed hyperkalemia with reduced urinary potassium excretion, accompanied by activation of renal mechanistic target of rapamycin complex 1 (mTORC1) signaling, indicated by increased phosphorylated S6, and decreased ROMK1 abundance in the plasma membrane fraction. Adrenal expression of aldosterone synthase Cyp11b2 and PAC were elevated, and ENaC activity was enhanced, as evidenced by increased cleavage of α‐ and γ‐ENaC subunits, partially compensating for impaired potassium excretion. Pharmacological ENaC inhibition with amiloride precipitated severe hyperkalemia in KLhet mice. In contrast, treatment with the mTORC1 inhibitor rapamycin or Klotho supplementation suppressed renal mTORC1 signaling, restored plasma membrane ROMK1 abundance, increased urinary potassium excretion, and normalized serum potassium levels, with reduced Cyp11b2 expression.

Conclusion

Klotho deficiency impairs renal potassium handling through mTORC1‐dependent downregulation of ROMK, with compensatory hyperaldosteronism and ENaC activation. These findings highlight an important role of the Klotho–mTORC1 axis in distal potassium homeostasis and its potential as a therapeutic target for Klotho deficiency–associated hyperkalemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mechanistic Target of Rapamycin Complex 1PotassiumHomeostasisPotassium Channels, Inwardly RectifyingGlucuronidaseHyperkalemiaAnimalsKlotho ProteinsMiceMice, KnockoutEpithelial Sodium ChannelsMaleSignal Transduction

Stichwörter der Autor:innen

KlothoROMKaldosteronedistal nephronhyperkalemiamTORC1renin–angiotensin system

Substanzen

Klotho ProteinsMechanistic Target of Rapamycin Complex 1PotassiumPotassium Channels, Inwardly RectifyingGlucuronidaseKcnj1 protein, mouseEpithelial Sodium Channels

Autor:innen und Institutionen

  • Center for Basic Medical Research, International University of Health and Welfare (IUHW), Narita, Chiba, Japan.
  • Department of Pharmacology, School of Medicine, IUHW, Narita, Chiba, Japan.
  • Department of Molecular Biology, School of Medicine, IUHW, Narita, Chiba, Japan.
  • Division of Clinical Epigenetics, Research Center for Advanced Science and Technology, The University of Tokyo, Meguro, Tokyo, Japan.
  • Department of Physiology, School of Medicine, IUHW, Narita, Chiba, Japan.

ORCID-Profile: Wakako Kawarazaki, Mitsuhiro Nishimoto, Daigoro Hirohama, Kohei Ueda, Takeshi Marumo, Toshiro Fujita

Förderung

  • Japan Society for the Promotion of Science
  • SENSHIN Medical Research Foundation
  • Takeda Science Foundation
  • Astellas Foundation for Research on Metabolic Disorders
  • Japanese Society of Hypertension
  • Japan Geriatrics Society
  • Naito Foundation
  • Harmonic Ito Foundation

Zitieren

APA

Kawarazaki, W., Ayuzawa, N., Nishimoto, M., Hirohama, D., Ueda, K., Marumo, T., & Fujita, T. (2026). Klotho Deficiency Impairs Distal Potassium Homeostasis Through mTORC1 ‐Dependent Suppression of ROMK. Acta Physiologica. https://doi.org/10.1111/apha.70325

Vancouver

Kawarazaki W, Ayuzawa N, Nishimoto M, Hirohama D, Ueda K, Marumo T, et al. Klotho Deficiency Impairs Distal Potassium Homeostasis Through mTORC1 ‐Dependent Suppression of ROMK. Acta Physiologica. 2026. doi:10.1111/apha.70325

BibTeX
@article{Kawarazaki2026,
  author = {Kawarazaki, Wakako and Ayuzawa, Nobuhiro and Nishimoto, Mitsuhiro and Hirohama, Daigoro and Ueda, Kohei and Marumo, Takeshi and Fujita, Toshiro},
  title = {Klotho Deficiency Impairs Distal Potassium Homeostasis Through mTORC1 ‐Dependent Suppression of ROMK},
  journal = {Acta Physiologica},
  year = {2026},
  doi = {10.1111/apha.70325}
}
Kostenlos starten →